GNOMX Corp. Gets License for Next-Gen Epigenetic Diagnostic Tech
The Icahn School of Medicine at Mount Sinai agreed to an exclusive license option with GNOMX Corp. for the disease diagnostic tech.
Read MorePosted by Andy Lundin | Sep 18, 2023 | Diagnostic Technologies |
The Icahn School of Medicine at Mount Sinai agreed to an exclusive license option with GNOMX Corp. for the disease diagnostic tech.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Clinical Chemistry Analyzers |
Carolina Liquid Chemistries Corp. now offers urine drug screens on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer.
Read MorePosted by Andy Lundin | Sep 12, 2023 | Breast |
The findings suggest the need for continued monitoring of access to breast cancer screening and early diagnosis services.
Read MorePosted by Andy Lundin | Sep 11, 2023 | Diagnostic Technologies |
The new novel method uses DNA Nanoballs to detect pathogens, and aims to simplify nucleic acid testing and revolutionize pathogen detection.
Read MorePosted by Andy Lundin | Sep 7, 2023 | Covid 19 |
Wearable technology has emerged as a potential innovation in the early detection of COVID-19 among NCAA Division I female student-athletes.
Read More